We are live on ! Find out more
NGNE icon

Neurogene

60 hedge funds and large institutions have $617M invested in Neurogene in 2024 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

357% more first-time investments, than exits

New positions opened: 32 | Existing positions closed: 7

233% more capital invested

Capital invested by funds: $186M → $617M (+$432M)

71% more funds holding

Funds holding: 3560 (+25)

19.71% more ownership

Funds ownership: 74.68%94.39% (+20%)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 10

Holders
60
Holders Change
+25
Holders Change %
+71.43%
% of All Funds
0.86%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
32
Increased
10
Reduced
10
Closed
7
Calls
Puts
Net Calls
Net Calls Change

NGNE Hedge Fund Activity: Q1 2024 in Review

60 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Neurogene (NGNE) for Q1 2024, worth a combined $617M — up 233% from $186M a quarter earlier.

Buyers outnumbered sellers: 32 funds opened new NGNE positions and 7 closed out — a net gain of 25 holders — while 10 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $27.7M. The largest seller was Cormorant Asset Management, cutting an estimated $6.93M.

  • 60 institutional investors held Neurogene (NGNE) as of Q1 2024, up from 35 in Q4 2023.
  • Funds reported $617M of Neurogene stock for Q1 2024, up 233% quarter-over-quarter.
  • 32 funds opened new Neurogene positions in Q1 2024 and 7 closed out, a net change of +25 holders.
  • The largest Neurogene buyer in Q1 2024 was BlackRock, an estimated $27.7M added.
  • The largest Neurogene seller in Q1 2024 was Cormorant Asset Management, an estimated $6.93M sold.

Based on aggregated 13F filings for Q1 2024.